Minirin Melt (Desmopressin)

Desmopressin is used to manage conditions related to antidiuretic hormone deficiency or bleeding disorders.

• Central diabetes insipidus: reduces excessive urine output by increasing water reabsorption.
• Nocturnal enuresis (bedwetting) in children: decreases nighttime urine production to reduce bedwetting episodes.
• Hemophilia A: raises plasma factor VIII levels to improve clotting.
• Von Willebrand disease: increases von Willebrand factor levels to enhance platelet adhesion.

• Desmopressin is a synthetic analog of vasopressin that selectively binds V2 receptors on the renal collecting duct epithelium, stimulating adenylate cyclase and raising cyclic AMP levels. This promotes insertion of aquaporin‑2 water channels, enhancing water reabsorption. V2 activation on endothelial cells also triggers release of stored factor VIII and von Willebrand factor, supporting hemostasis.

Desmopressin may cause a range of adverse reactions, from mild to serious.

Common Side Effects

• Headache: mild throbbing pain.
• Nausea: occasional upset stomach.
• Nasal congestion: feeling of a blocked nose.
• Hyponatremia: mild reduction in blood sodium levels.

Serious or Rare Side Effects

• Severe hyponatremia: can lead to confusion, seizures, or coma.
• Thrombotic events: rare clot formation.
• Anaphylaxis: rare severe allergic reaction.

Before initiating therapy, consider the following precautions.

• Monitor fluid intake: limit excessive water to reduce hyponatremia risk.
• Assess serum sodium: check baseline and periodically during treatment.
• Use caution in renal impairment: reduced clearance may increase drug effect.
• Avoid in uncontrolled hypertension: V2 activation may affect blood pressure.
• Pregnancy and lactation: safety not established; use only if benefits outweigh risks.
• Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture.

Desmopressin can interact with several medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid)

• Other ADH analogs (e.g., vasopressin): additive antidiuretic effect, risk of water intoxication.
• NSAIDs (e.g., ibuprofen, naproxen): may potentiate antidiuretic action and hyponatremia.
• Carbamazepine: reduces desmopressin efficacy.

Moderate Interactions (Monitor Closely)

• Diuretics (especially thiazides): increase risk of hyponatremia.
• Anticoagulants (e.g., warfarin): may affect hemostatic response.
• SSRIs: potential for hyponatremia.